280: ESMO highlights, Roivant's big deal, & biotech VC on the rise

The podcast discusses the highlights of a recent oncology conference, including advancements in cancer-treating technology. It also covers the future of Alzheimer's disease treatment, a multibillion-dollar biotech deal, and the rise of biotech venture capital. The hosts explore the incredible math behind a biotech investment that turned $50 million into $5 billion. They also discuss the challenges faced by the biotech industry, recent developments in Alzheimer's treatment, and advancements in antibody-drug conjugates for cancer treatment.